News & Insights

On December 12, 2024, the research team led by Jia Jing from the School of Chemistry and Chemical Engineering, Nanjing University, published findings in *Small*. Supported by the Nexcope NCF Confocal Microscope, this study constructed cancer‑cell‑membrane‑camouflaged nanoprobe TCC@M based on Ti₃C₂ MXene. It integrates a photo‑dynamically activated CRISPR‑Cas9 system for targeted delivery and spatiotemporally controllable gene regulation. Combined with the photothermal properties of MXene, enhanced photothermal therapy is realized, while multi‑modal imaging (fluorescence / photoacoustic / thermal) is incorporated to guide treatment. This technology addresses clinical bottlenecks of conventional combined cancer therapy, including poor synergy, single spatiotemporal control, lack of real‑time monitoring, and limited tissue penetration of light‑controlled gene regulation. It achieves efficient cancer therapy under mild temperatures with favorable targeting, safety and precision, offering an innovative synergistic strategy for precise cancer diagnosis and treatment.

From March 21 to 23, 2026, the 23rd China International Clinical Laboratory & Transfusion Medicine Instrument & Reagent Exhibition (CACLP) and the 6th China International IVD Raw Material & Supply Chain Expo (CISCE) grandly opened in Xiamen. Ningbo Yongxin Optics Co., Ltd. showcased a full portfolio of core microscope components for in vitro diagnostics (IVD). With cutting-edge optical technologies, Yongxin Optics empowers the upstream IVD supply chain, accelerates the upgrading of medical testing equipment, and jointly shapes a new landscape of multi-scenario precision medical applications.

Held from January 20‑22, 2026, SPIE Photonics West is one of the world’s largest photonics events. More than 1,000 exhibitors gathered at the show to present the latest breakthroughs and future trends in global photonics technology.